Literature DB >> 10765160

A Clinical Study of Protein Sparing Modified Fast (PSMF) Administered Preoperatively to Morbidly Obese Patients: comparison of PSMF with natural food products to originally prepared PSMF.

.   

Abstract

Morbidly obese patients are generally in a malnutritional state with an extremely high operative risk. In order to reduce the operative risk, surgeons should make every effort before the operation. A protein sparing modified fast (PSMF) may exhibit its high effectiveness when taken at least for 2 weeks preoperatively. In this study, PSMF prescribed with natural food products was compared with prepared PSMF having an ideal composition from the clinical standpoint. Though it is natural for patients to favor the former, the latter proved to have a superior effect in clinical practice. By performing a PSMF for 2 weeks preoperatively, however, even the PSMF with natural food products seemed to fulfill its purpose sufficiently.

Entities:  

Year:  1992        PMID: 10765160     DOI: 10.1381/096089292765560510

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  3 in total

Review 1.  Protein sparing therapies in acute illness and obesity: a review of George Blackburn's contributions to nutrition science.

Authors:  Dylan D Thomas; Nawfal W Istfan; Bruce R Bistrian; Caroline M Apovian
Journal:  Metabolism       Date:  2017-12-07       Impact factor: 8.694

2.  A 2-Week Course of Enteral Treatment with a Very Low-Calorie Protein-Based Formula for the Management of Severe Obesity.

Authors:  Giuseppe Castaldo; Luigi Monaco; Laura Castaldo; Paolo Sorrentino
Journal:  Int J Endocrinol       Date:  2015-05-06       Impact factor: 3.257

3.  Feasibility of protein-sparing modified fast by tube (ProMoFasT) in obesity treatment: a phase II pilot trial on clinical safety and efficacy (appetite control, body composition, muscular strength, metabolic pattern, pulmonary function test).

Authors:  S G Sukkar; A Signori; C Borrini; G Barisione; C Ivaldi; C Romeo; R Gradaschi; N Machello; E Nanetti; A L Vaccaro
Journal:  Med J Nutrition Metab       Date:  2013-05-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.